Cite
Poles MZ, Nászai A, Gulácsi L, et al. Kynurenic Acid and Its Synthetic Derivatives Protect Against Sepsis-Associated Neutrophil Activation and Brain Mitochondrial Dysfunction in Rats. Front Immunol. 2021;12:717157doi: 10.3389/fimmu.2021.717157.
Poles, M. Z., Nászai, A., Gulácsi, L., Czakó, B. L., Gál, K. G., Glenz, R. J., Dookhun, D., Rutai, A., Tallósy, S. P., Szabó, A., Lőrinczi, B., Szatmári, I., Fülöp, F., Vécsei, L., Boros, M., Juhász, L., & Kaszaki, J. (2021). Kynurenic Acid and Its Synthetic Derivatives Protect Against Sepsis-Associated Neutrophil Activation and Brain Mitochondrial Dysfunction in Rats. Frontiers in immunology, 12717157. https://doi.org/10.3389/fimmu.2021.717157
Poles, Marietta Z, et al. "Kynurenic Acid and Its Synthetic Derivatives Protect Against Sepsis-Associated Neutrophil Activation and Brain Mitochondrial Dysfunction in Rats." Frontiers in immunology vol. 12 (2021): 717157. doi: https://doi.org/10.3389/fimmu.2021.717157
Poles MZ, Nászai A, Gulácsi L, Czakó BL, Gál KG, Glenz RJ, Dookhun D, Rutai A, Tallósy SP, Szabó A, Lőrinczi B, Szatmári I, Fülöp F, Vécsei L, Boros M, Juhász L, Kaszaki J. Kynurenic Acid and Its Synthetic Derivatives Protect Against Sepsis-Associated Neutrophil Activation and Brain Mitochondrial Dysfunction in Rats. Front Immunol. 2021 Aug 12;12:717157. doi: 10.3389/fimmu.2021.717157. eCollection 2021. PMID: 34475875; PMCID: PMC8406694.
Copy
Download .nbib